Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BEATW - HeartBeam Inc - Warrants (31/10/2026)


IEX Last Trade
0.5037
-0.046   -9.192%

Share volume: 2,115
Last Updated: Fri 30 Aug 2024 09:59:18 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$0.55
-0.05
-8.42%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
2.82%
1 Month
0.74%
3 Months
-34.58%
6 Months
179.83%
1 Year
7.86%
2 Year
48.85%
Key data
Stock price
$0.50
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.09 - $1.23
52 WEEK CHANGE
$0.26
MARKET CAP 
62.421 M
YIELD 
N/A
SHARES OUTSTANDING 
2.750 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,113
AVERAGE 30 VOLUME 
$4,789
Company detail
CEO:
Region: US
Website:
Employees: 18
IPO year: -
Issue type:
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.

Recent news